The regulation of immune cells by Lactobacilli: a potential therapeutic target for anti-atherosclerosis therapy.
- 2017-06-02
- Oncotarget 8(35)
- Ya-Hui Ding
- Lin-Yan Qian
- Jie Pang
- Jing-Yang Lin
- Qiang Xu
- Li-Hong Wang
- Dong-Sheng Huang
- Hai Zou
- PubMed: 28938693
- DOI: 10.18632/oncotarget.18346
Study Design
- Type
- Review
Research Insights
Some Lactobacillus stains can upregulate the activity of regulatory T-lymphocytes, suppress T-lymphocyte helper (Th) cells Th1, Th17, alter the Th1/Th2 ratio, influence the subsets ratio of M1/M2 macrophages, inhibit foam cell formation by suppressing macrophage phagocytosis of oxidized low-density lipoprotein, block the activation of the immune system with dendritic cells, which are expected to suppress the atherosclerosis-related inflammation.
- Effect
- Beneficial
- Effect size
- Small
Some <i>Lactobacillus</i> stains can upregulate the activity of regulatory T-lymphocytes, suppress T-lymphocyte helper (Th) cells Th1, Th17, alter the Th1/Th2 ratio, influence the subsets ratio of M1/M2 macrophages, inhibit foam cell formation by suppressing macrophage phagocytosis of oxidized low-density lipoprotein, block the activation of the immune system with dendritic cells, which are expected to suppress the atherosclerosis-related inflammation.
- Effect
- Beneficial
- Effect size
- Moderate